Yuanjie MAO, Takeshi Tokudome, Ichiro Kishimoto. The cardiovascular action of hexarelin[J]. Journal of Geriatric Cardiology, 2014, 11(3): 253-258. DOI: 10.11909/j.issn.1671-5411.2014.03.007
Citation: Yuanjie MAO, Takeshi Tokudome, Ichiro Kishimoto. The cardiovascular action of hexarelin[J]. Journal of Geriatric Cardiology, 2014, 11(3): 253-258. DOI: 10.11909/j.issn.1671-5411.2014.03.007

The cardiovascular action of hexarelin

  • Hexarelin, a synthetic growth hormone-releasing peptide, can bind to and activate the growth hormone secretagogue receptor (GHSR) in the brain similar to its natural analog ghrelin. However, the peripheral distribution of GHSR in the heart and blood vessels suggests that hexarelin might have direct cardiovascular actions beyond growth hormone release and neuroendocrine effects. Furthermore, the non-GHSR CD36 had been demonstrated to be a specific cardiac receptor for hexarelin and to mediate its cardioprotective effects. When compared with ghrelin, hexarelin is chemically more stable and functionally more potent. Therefore, it may be a promising therapeutic agent for some cardiovascular conditions. In this concise review, we discuss the current evidence for the cardiovascular action of hexarelin.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return